In a world of copper-based medicine, copper sulfate, a chemical used in modern medical devices, is often prescribed to treat copper poisoning.
But there’s a problem: The chemical is toxic, and it’s very hard to regulate, and its use is becoming a huge health issue.
That’s why the copper-sulfur debate is heating up in Canada.
Copper-based medicines are popular with some physicians, and their use has exploded in the last few years, according to the Canadian Medical Association.
But it’s also made headlines in the United States.
In 2016, two researchers in Michigan state reported finding a high rate of copper poisoning among people taking the copper sulfide tablet.
In a study published in the journal Clinical Toxicology, Dr. Matthew D. Pascall and Dr. Paul M. Piscatella from the University of Michigan found that, while only 5 percent of people taking copper sulfates had symptoms, about 35 percent of patients experienced some sort of symptoms.
In an attempt to address the issue, the Canadian government recently proposed a bill that would limit the use of copper sulfides in the U.S.
Pascall said the bill, which would also require companies to report on the number of people who have died from copper poisoning, is a “good first step” toward reducing the risk of copper disease.
Coppersulfide tablets are available in many different forms, including a tablet called Copper Sulfide-Bathroom (Copper Sulfur Bath) that comes in a glass tube.
Copper sulfide tablets were previously marketed as a cure-all for copper poisoning in the UK, but that has been challenged by some.
In the U, there are several other medications used to treat symptoms of copper, but they’re not as well studied and are not regulated.
The Canadian government is also working on legislation to create a copper-related drug regulatory framework that would allow the use and marketing of products to prevent copper poisoning as well as limit its use for therapeutic purposes.
The idea of a regulated copper-containing drug seems like a good one, but it could be a difficult road to navigate.
The Copper Institute, a nonprofit advocacy group, says it’s trying to get legislation passed to help with the regulation of copper in the Canadian market.
“We think it’s an important step forward,” said co-director of the institute, Dan Kivimaki.
“We think we can help a lot of people get back on their feet.”